开发慢性病查综合护理模型,由社区药剂师领导
Piangkwan Srimongkhol1,2, Sirirat Anutrakulchai3, Amponpun Theeranut4
1College of Pharmacotherapy Thailand, Nonthaburi 11000, Thailand.
Pharmacy (Basel, Switzerland)
|February 25, 2025
概括
社区药房可以查白蛋白尿,以预防慢性病 (CKD). 药剂师的干预改善了风险人群的自我管理行为,有助于预防CKD的努力.
科学领域:
- 药理学和公共卫生
- 腎臟醫學 腎臟醫學
- 社区药房实践 社区药房实践
背景情况:
- 慢性病 (CKD) 的流行率不断上升,需要采取积极的预防策略.
- 社区药房是可访问的医疗保健点,用于早期发现和干预CKD.
- 开发有效的社区药房护理模式对于管理高风险人群至关重要.
研究的目的:
- 开发和评估基于社区药房的护理模式,以预防CKD.
- 为了优化药物使用,促进行为变化,并支持患有CKD风险的个体的自我管理.
- 评估社区药剂师在减缓CKD进展中的作用.
主要方法:
- 从2017年6月到2018年7月进行的行动研究方法.
- 由社区药剂师使用尿液测量棒进行微蛋白尿症查.
- 实施行为改变和自我管理支持 (SMS) 策略,并在12周后进行随访.
主要成果:
- 在521名接受查的参与者中,57%的参与者呈白尿阳性,这促使进一步调查和转诊.
- 在自我管理行为评估 (S1) 评分显著改善 (p = 0.024).
- 确定了与白尿相关的关键因素,包括年龄,糖尿病,高血压,BMI,eGFR,血压和葡萄糖水平.
结论:
- 社区药剂师主导的白蛋白尿查是预防CKD的有效策略.
- 这种方法提高了社区对脏健康的自我意识.
- 药剂师的干预可以积极影响患有CKD风险的个体的自我管理行为.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
Renal Drug Clearance: Overview
103
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
103
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
38
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
38
Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
54
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
54
Restorative Care
1.9K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
1.9K


